INDEX / LIFE SCIENCES TOOLS / CRDG

Cardinal Genomics

CRDG · Nasdaq Managed by Cardinal Genomics

Cardinal Genomics builds long-read sequencing instruments and the assays that run on them. The filing names a focused set of rivals, but the trailing quarter has stayed quiet — no public competitive moves in the window we track, which is itself a kind of signal.

S-1 named 5 competitors — 19 references to sequencing incumbents. Below: what the filing revealed, mapped against the field.

Listed

Apr 30, 2026

Raised

$280M

Sector

Life Sciences Tools · Genomics

Coverage

Unclaimed Claimed

What the S-1 revealed

3 disclosures · extracted

Positions itself as instrument-agnostic middleware, naming the incumbents it sits on top of.

S-1 · "Competition" p. 21

Discloses that three customers account for 41% of revenue — all of them named rivals' partners.

S-1 · "Risk Factors" p. 16

Cites reagent lock-in from sequencing vendors as the structural risk to its open-platform pitch.

S-1 · "Risk Factors" p. 27

The field Cardinal Genomics named

5 competitors · from the S-1

Cardinal Genomics

CRDG · the filer

Helix Instruments

named 8×

Provenance Bio

named 5×

Sequora

named 3×

Aria Biosystems

named 2×

Caldera Labs

named 1×

Node size is uniform edges weighted by S-1 mention count last refreshed Apr 30, 2026

Share of presence

preview · cropped

Preview · Publictoday

Helix Instruments

31%

Cardinal Genomics

17%

Aria Biosystems

Provenance Bio

12%

Sequora

Full map ranks 9 competitors by share of presence 4 not named in the S-1

Signal timeline

competitor moves · last 90 days

No public signals in the trailing window — 64 tracked

Jun 01, 2026 ▓▓▓▓▓▓▓▓ ▓▓▓▓▓▓▓ ▓ ▓▓▓-▓▓▓▓▓▓▓▓▓ ▓▓▓▓▓▓ ▓▓▓▓ ▓▓▓ ▓▓ ▓▓▓ ▓▓▓▓▓▓▓ ▓▓▓▓▓▓▓▓ ▓▓▓▓▓.

May 19, 2026 ▓▓▓▓▓▓▓▓▓▓ ▓▓▓▓▓▓▓▓ ▓ ▓▓▓▓▓▓▓ ▓▓▓▓▓▓ ▓▓▓▓ ▓▓ ▓▓▓ ▓▓▓▓▓▓▓▓▓▓ ▓▓▓▓▓▓▓ ▓▓▓▓▓.

May 04, 2026 ▓▓▓▓▓ ▓▓▓▓▓▓ ▓▓▓ ▓▓▓-▓▓▓▓▓▓▓ ▓▓▓▓▓▓▓▓▓ ▓▓ ▓ ▓▓▓▓▓ ▓.▓. ▓▓▓▓▓▓▓▓ ▓▓▓▓▓▓.

Is this your company?

Claim your competitive profile to unlock the other 4 competitors we mapped beyond your S-1, the full share-of-presence breakdown, and 64 more signals from the last 90 days.

Claim your competitive profile Verify with your @cardinalgenomics.com email · report in 48h

This profile is claimed.

Verified and managed by Cardinal Genomics since Jun 12, 2026. Your full Exposure Report — all 9 competitors, the presence map, and 64 signals — is ready.